2 terminated, 1 recruiting. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 1, Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow (11C)-MC1: new trials by email Literature Review of (11C)-MC1 trials Research Report on (11C)-MC1
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PET Imaging of Cyclooxygenase in Multiple Sclerosis 11C-MC1, 11C-PS13, Ketoprofen - Multiple Sclerosis | Phase 2 | Terminated | National Institute of Mental Health (NIMH) | 7 | 2022-06-07 | 2024-06-27 |
| PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease 11C-MC1, 11C-PS13, 18f-florbetaben - Parkinson's Disease, Dementia | Phase 1 | Recruiting | National Institute of Mental Health (NIMH) | 184 | 2021-08-17 | 2026-11-02 |
| Novel PET Radioligand as an Inflammatory Biomarker in Musculoskeletal Conditions 11C-MC1, Celecoxib, [11C]ER176 - Myositis, Inflammatory | Phase 1 | Terminated | National Institute of Mental Health (NIMH) | 31 | 2019-06-14 | 2025-09-16 |
Alzheimer Disease (1) · Arthritis, Rheumatoid (1) · Cognitive Dysfunction (1) · Dementia (1) · Inflammation (1) · Multiple Sclerosis (1) · Myositis (1) · Neuroinflammatory Diseases (1) · Neurologic Manifestations (1) · Parkinson Disease (1)
National Institute of Mental Health (NIMH) (3)
United States (3)